Lotte Holm Land

Summary

Affiliation: Odense University Hospital
Country: Denmark

Publications

  1. pmc Influence of comorbidity on the effect of adjuvant treatment and age in patients with early-stage breast cancer
    L H Land
    Department of Oncology, Odense University Hospital, Sdr Boulevard 29, Odense C 5000, Denmark
    Br J Cancer 107:1901-7. 2012
  2. doi Comorbidity and survival after early breast cancer. A review
    Lotte Holm Land
    Department of Oncology, Odense University Hospital, Denmark
    Crit Rev Oncol Hematol 81:196-205. 2012
  3. doi Impact of comorbidity on mortality: a cohort study of 62,591 Danish women diagnosed with early breast cancer, 1990-2008
    Lotte Holm Land
    Department of Oncology, Odense University Hospital, Sdr Boulevard 29, 5000, Odense C, Denmark
    Breast Cancer Res Treat 131:1013-20. 2012

Collaborators

Detail Information

Publications3

  1. pmc Influence of comorbidity on the effect of adjuvant treatment and age in patients with early-stage breast cancer
    L H Land
    Department of Oncology, Odense University Hospital, Sdr Boulevard 29, Odense C 5000, Denmark
    Br J Cancer 107:1901-7. 2012
    ..The aim of this study was to examine the effect of breast cancer treatment on mortality, taking age at diagnosis and comorbidity into account...
  2. doi Comorbidity and survival after early breast cancer. A review
    Lotte Holm Land
    Department of Oncology, Odense University Hospital, Denmark
    Crit Rev Oncol Hematol 81:196-205. 2012
    ..Survival after breast cancer is determined by disease related factors such as stage at diagnosis, patient characteristics, e.g., age, and treatment...
  3. doi Impact of comorbidity on mortality: a cohort study of 62,591 Danish women diagnosed with early breast cancer, 1990-2008
    Lotte Holm Land
    Department of Oncology, Odense University Hospital, Sdr Boulevard 29, 5000, Odense C, Denmark
    Breast Cancer Res Treat 131:1013-20. 2012
    ..While survival improved over time for patients without comorbidity, no improvement was seen among patients with severe comorbidity (CCI 3+)...